FDA
-
-
-
-
-
-
-
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026
-
-
-
-
-
-
-
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
-
-
-
-
-
-
-
Here’s What Investors Are Watching, Including $20 Price Target Bombshell
-
-
-
-
-
-
-
NeOnc redeems $6M in preferred stock with cash, avoiding dilution
-
-
-
-
-
-
-
Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
-
-
-
-
-
-
-
NeOnc' Phase 2 Data Could Put Cancer on the Ropes
-
-
-
-
-
-
-
These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


